32 filings
1-K
2020 FY
Cannabinoid Biosciences, Inc.
28 Apr 21
Annual report
10:44am
1-K/A
2019 FY
Cannabinoid Biosciences, Inc.
16 Dec 20
Annual report (amended)
2:29pm
1-SA
Cannabinoid Biosciences, Inc.
19 Oct 20
Semiannual report
2:15pm
QUALIF
Cannabinoid Biosciences, Inc.
10 Jun 20
Notice of qualification
12:15am
CORRESP
Cannabinoid Biosciences, Inc.
8 Jun 20
Correspondence with SEC
12:00am
1-A POS
f7lrifmwpixt9k
29 May 20
Offering $50M in Equity
4:47pm
CORRESP
9yk7n 4a9e
29 May 20
Correspondence with SEC
12:00am
UPLOAD
eum1 msc15cmx5xw8
28 May 20
Letter from SEC
12:00am
1-A POS
1iz31 b0h
20 May 20
Offering $50M in Equity
2:11pm
1-A POS
itxtxl93x4u2noukj1g0
1 May 20
Offering $50M in Equity
5:19pm
1-K
gpcyefxgtkrk784 7q1
30 Apr 20
Annual report
4:37pm
1-SA
g1sagbq lhf0a
30 Apr 20
Semiannual report
3:49pm
1-U
u2ars5
7 Feb 20
Current report (pursuant to Regulation A)
4:19pm
1-U
nih49u dwb37rw59xgu
6 Jan 20
Current report (pursuant to Regulation A)
9:55pm
1-U
h9yp6ppa7a414a
10 Sep 19
Current report (pursuant to Regulation A)
12:00am
253G2
imvkf873az2m
30 Aug 19
Offering circular supplement
12:00am
253G2
vbf qmab6jxv
19 Aug 19
Offering circular supplement
12:41pm
1-SA
ic5e1 gyazrbh
19 Aug 19
Semiannual report
12:00am
1-U/A
ujfpa
19 Aug 19
Current report (pursuant to Regulation A) (amended)
12:00am
253G2
rui4bm86kspsyr2lq3b
19 Aug 19
Offering circular supplement
12:00am